Pseudaminic Acid

Pseudaminic acid (Pse), a sialic acid-like nonulosonic acid (NulO) monosaccharide, is integral to the structure and functionality of prokaryotic cell-surface-associated glycoconjugates, including the flagellar protein flagellin, lipopolysaccharides, and capsules of bacteria such as Pseudomonas aeruginosa, Vibrio vulnificus, Plesiomonas shigelloides, Bacillus thuringiensis, and Campylobacter jejuni. This structural similarity to sialic acid, Neu5Ac, underscores its vital role in bacterial motility and biofilm formation, with its presence being essential for the assembly and function of bacterial flagella. The unique role of Pse as a target for antibacterial therapy development, coupled with its significance in bacterial pathogenesis, paves the way for novel vaccines and therapeutic strategies. Additionally, the exploration of Pse's biosynthetic pathways offers potential biotechnological applications, including the bioengineering of bacteria for the production of specialized glycosylated proteins, leveraging the sialic acid-like properties of this nonulosonic acid for innovative solutions in medicine and biotechnology.

Other Names: Pse; Pse5Ac7Ac; Pse5,7Ac; 5,7-bis(acetylamino)- 3,5,7,9-tetradeoxy-L-glycero-α-L-manno-2-nonulopyranosonic acid; 5,7-diacetamido- 3,5,7,9-tetradeoxy- L-glycero- α- L-manno- non- 2-ulopyranosonic acid